Ingen HBV- DNA - polymerase- mutationer forbundet med resistens over for adefovir blev identificeret, da patienter blev genotypeanalyseret ved baseline og uge 48.
No HBV DNA polymerase mutations associated with resistance to adefovir were identified when patients were genotyped at baseline and at week 48.